6730 Stock Overview
A medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
Lagis Enterprise Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$37.90 |
52 Week High | NT$50.20 |
52 Week Low | NT$35.85 |
Beta | 0.0055 |
11 Month Change | -0.66% |
3 Month Change | -1.56% |
1 Year Change | -2.57% |
33 Year Change | 20.70% |
5 Year Change | -34.22% |
Change since IPO | -48.46% |
Recent News & Updates
Recent updates
Be Wary Of Lagis Enterprise (GTSM:6730) And Its Returns On Capital
Mar 23Are Lagis Enterprise Co., Ltd.'s (GTSM:6730) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Jan 20Factors Income Investors Should Consider Before Adding Lagis Enterprise Co., Ltd. (GTSM:6730) To Their Portfolio
Dec 14Shareholder Returns
6730 | TW Medical Equipment | TW Market | |
---|---|---|---|
7D | 2.4% | 0.5% | 0.8% |
1Y | -2.6% | 0.7% | 30.3% |
Return vs Industry: 6730 underperformed the TW Medical Equipment industry which returned 0.7% over the past year.
Return vs Market: 6730 underperformed the TW Market which returned 30.3% over the past year.
Price Volatility
6730 volatility | |
---|---|
6730 Average Weekly Movement | 3.6% |
Medical Equipment Industry Average Movement | 3.9% |
Market Average Movement | 4.6% |
10% most volatile stocks in TW Market | 8.0% |
10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6730 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6730's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | n/a | Zhengxiong Chen | www.lagis.com.tw |
Lagis Enterprise Co., Ltd., a medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide. Its products include trocars, single port surgery devices, and wound protectors; endo devices, such as hand instruments and advanced bipolar devices; specimen retrieval products; suction irrigation systems and irrigation pumps; training systems; and related accessories. The company was founded in 1993 and is headquartered in Taichung, Taiwan.
Lagis Enterprise Co., Ltd. Fundamentals Summary
6730 fundamental statistics | |
---|---|
Market cap | NT$1.21b |
Earnings (TTM) | NT$72.80m |
Revenue (TTM) | NT$474.03m |
16.7x
P/E Ratio2.6x
P/S RatioIs 6730 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6730 income statement (TTM) | |
---|---|
Revenue | NT$474.03m |
Cost of Revenue | NT$248.66m |
Gross Profit | NT$225.38m |
Other Expenses | NT$152.58m |
Earnings | NT$72.80m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 2.27 |
Gross Margin | 47.54% |
Net Profit Margin | 15.36% |
Debt/Equity Ratio | 43.5% |
How did 6730 perform over the long term?
See historical performance and comparison